BIOA
BioAge Labs, Inc. Common Stock
BIOA
BIOA
67 hedge funds and large institutions have $76.2M invested in BioAge Labs, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
+2
Holders Change %
+3.08%
% of All Funds
0.91%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
15
Increased
16
Reduced
18
Closed
12
Calls
–
Puts
$765K
Net Calls
-$765K
Net Calls Change
-$765K
Top Buyers
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$3.19M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.28M |
| 3 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.06M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$272K |
| 5 |
State Street
Boston,
Massachusetts
|
+$216K |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.55M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$970K |
| 3 |
Goldman Sachs
New York
|
-$636K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$324K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$272K |
